Medical News

RSS

HHV cleared of all lawsuit charges, continues to help veterans and their families

Help Hospitalized Veterans (HHV), the charitable organization that for more than 42 years has helped in the recovery of wounded, sick or disabled American veterans, announced today that the lawsuit brought by the California attorney general had been settled and that HHV will continue helping veterans reclaim their lives.

7 Sep 2013

Study analyzes factors associated with outsourcing clinical trial activities

It's no secret that the medical device sector sees emerging markets such as China and Brazil as their best opportunity for top-line growth over the next decade.

7 Sep 2013

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

The Diabetes Hands Foundation announced today that it will send diabetes advocate Bennet Dunlap to participate on a panel September 9, 2013 aiming to address the growing concerns around blood glucose test strip accuracy.

7 Sep 2013

Software manipulates 3-D holograms of various organs obtained from ultrasound, CT or MRI scans

Recently converted in one of the youngest residents of Silicon Valley, California, the high-tech Mexican enterprise Echopixel created software that allows the medical doctor to look and manipulate on their desk third dimension (3-D) holograms of various organs obtained from ultrasound, CT or MRI scans.

7 Sep 2013

United Medical Education launches new blog post that explains BLS and BCLS certifications

United Medical Education, an online company that provides students with the resources to obtain their ACLS, PALS, and BLS certificates, recently announced the launch of a new blog post that explains BLS and BCLS certifications.

7 Sep 2013

New book debunks popular myths on how to prevent cancer

Award-winning science journalist George Johnson debunks popular assumptions about how to prevent cancer.

7 Sep 2013

Health Care REIT participates in the Bank of America Merrill Lynch 2013 Global Real Estate Conference

Health Care REIT, Inc. announced today that the company will participate in the Bank of America Merrill Lynch 2013 Global Real Estate Conference at the Westin Times Square in New York, New York. Corporate materials will be available on the Investor Relations section of Health Care REIT's website (www.hcreit.com) on Tuesday, September 10, 2013.

7 Sep 2013

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Wockhardt USA, LLC and Wockhardt Ltd. (collectively, "Wockhardt") to resolve pending patent litigation in response to Wockhardt's abbreviated new drug application (ANDA) seeking approval to market generic versions of Avanir's NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) capsules.

7 Sep 2013

ACE serves as official training partner for Competitor's Women's Running Series

American Council on Exercise (ACE) has partnered with Competitor Group, Inc. to serve as the official training partner for Competitor's Women's Running Series. Comprised of four races across the country, the Women's Running Series offers 5Ks and half-marathon events that are both walker and runner-friendly.

7 Sep 2013

Altaire Pharmaceuticals recalls 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution

Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling a total of nine (9) lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution, 30 mL, to the consumer level. There have been no reports of adverse effects to consumers so far.

7 Sep 2013

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

Adheris, Inc., an inVentiv Health company, filed suit today against the U.S. Department of Health and Human Services, asking a federal court to enjoin the government from implementing a new regulation that imposes unconstitutional restrictions on the speech of a company whose business is encouraging patients to properly take their medicine.

7 Sep 2013

FDA approves ABRAXANE chemotherapy drug for treatment of metastatic pancreatic cancer

The Pancreatic Cancer Action Network is pleased to announce that today ABRAXANE® was approved by the U.S. Food and Drug Administration (FDA) to treat metastatic pancreatic cancer.

7 Sep 2013

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

The use of nanopore technology aimed at more accurate and efficient DNA sequencing is the main focus of grants awarded by the National Institutes of Health. The grants - nearly $17 million to eight research teams - are the latest awarded through the National Human Genome Research Institute (NHGRI)'s Advanced DNA Sequencing Technology program, which was launched in 2004. NHGRI is part of NIH.

7 Sep 2013

State highlights: N.M. high court rules malpractice law covers doc businesses

A selection of health policy stories from Texas, New Mexico, California, South Carolina, Iowa, Florida, Minnesota and Massachusetts.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

For health exchanges, will soft launches lead to hard landings?

CQ HealthBeat examines whether the new online insurance marketplaces will be ready to go on Oct. 1, and what possible delays might emerge and how those delays could impact the exchanges' effectiveness. Also in the headlines, reports from Delaware, Kentucky, Washington, Pennsylvania, Arizona and Georgia.

7 Sep 2013

Enzymatics buys Boulder-based ArcherDx

Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.

7 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

D&A PHARMA, a leading company in the Addiction therapeutic area, announces today its strong participation in the 14th Congress of European Company of Biomedical Search on the Alcoholism (ESBRA), which will be held in Warsaw from September 8th to 11th.

7 Sep 2013

Mutual of Omaha announces new Critical Illness insurance product

Mutual of Omaha, a leading provider of group benefits, has announced a new Critical Illness product that allows employers to enhance their benefits coverage, while providing employees and their loved ones with added protection if a critical illness occurs.

7 Sep 2013

Medical News

HHV cleared of all lawsuit charges, continues to help veterans and their families

Study analyzes factors associated with outsourcing clinical trial activities

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

Software manipulates 3-D holograms of various organs obtained from ultrasound, CT or MRI scans

United Medical Education launches new blog post that explains BLS and BCLS certifications

New book debunks popular myths on how to prevent cancer

Health Care REIT participates in the Bank of America Merrill Lynch 2013 Global Real Estate Conference

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

ACE serves as official training partner for Competitor's Women's Running Series

Altaire Pharmaceuticals recalls 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

FDA approves ABRAXANE chemotherapy drug for treatment of metastatic pancreatic cancer

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

State highlights: N.M. high court rules malpractice law covers doc businesses

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

For health exchanges, will soft launches lead to hard landings?

Enzymatics buys Boulder-based ArcherDx

Research roundup: The financial burden of hospital acquired infections

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

Mutual of Omaha announces new Critical Illness insurance product

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News